BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Daneshvar Kakhaki R, Ostadmohammadi V, Kouchaki E, Aghadavod E, Bahmani F, Tamtaji OR, J Reiter R, Mansournia MA, Asemi Z. Melatonin supplementation and the effects on clinical and metabolic status in Parkinson's disease: A randomized, double-blind, placebo-controlled trial. Clin Neurol Neurosurg 2020;195:105878. [PMID: 32417629 DOI: 10.1016/j.clineuro.2020.105878] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang X, Zhang Y, Zhou Y, Liu Z, Wei B, Feng X. Melatonin in Different Food Samples: Recent Update on Distribution, Bioactivities, Pretreatment and Analysis Techniques. Food Research International 2022. [DOI: 10.1016/j.foodres.2022.112272] [Reference Citation Analysis]
2 Fan R, Bu X, Yang S, Tan Y, Wang T, Chen H, Li X. Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials. BMJ Open 2022;12:e060912. [PMID: 36104141 DOI: 10.1136/bmjopen-2022-060912] [Reference Citation Analysis]
3 Liguori C, Fernandes M, Cerroni R, Ludovisi R, Mercuri NB, Stefani A, Pierantozzi M. Effects of melatonin prolonged-release on both sleep and motor symptoms in Parkinson’s disease: a preliminary evidence. Neurol Sci 2022;43:5355-5362. [DOI: 10.1007/s10072-022-06111-x] [Reference Citation Analysis]
4 Ramanzini LG, Camargo LFM, Silveira JOF, Bochi GV. Inflammatory markers and depression in Parkinson’s disease: a systematic review. Neurol Sci 2022. [DOI: 10.1007/s10072-022-06363-7] [Reference Citation Analysis]
5 Kholghi G, Eskandari M, Shokouhi Qare Saadlou MS, Zarrindast MR, Vaseghi S. Night shift hormone: How does melatonin affect depression? Physiol Behav 2022;252:113835. [PMID: 35504318 DOI: 10.1016/j.physbeh.2022.113835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ong WY, Leow DM, Herr DR, Yeo CJ. What Do Randomized Controlled Trials Inform Us About Potential Disease-Modifying Strategies for Parkinson's Disease? Neuromolecular Med 2022. [PMID: 35776238 DOI: 10.1007/s12017-022-08718-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li C, Ma D, Li M, Wei T, Zhao X, Heng Y, Ma D, Anto EO, Zhang Y, Niu M, Zhang W. The Therapeutic Effect of Exogenous Melatonin on Depressive Symptoms: A Systematic Review and Meta-Analysis. Front Psychiatry 2022;13:737972. [DOI: 10.3389/fpsyt.2022.737972] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ma H, Yan J, Sun W, Jiang M, Zhang Y. Melatonin Treatment for Sleep Disorders in Parkinson's Disease: A Meta-Analysis and Systematic Review. Front Aging Neurosci 2022;14:784314. [DOI: 10.3389/fnagi.2022.784314] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Salemi M, Lanza G, Mogavero MP, Cosentino FII, Borgione E, Iorio R, Ventola GM, Marchese G, Salluzzo MG, Ravo M, Ferri R. A Transcriptome Analysis of mRNAs and Long Non-Coding RNAs in Patients with Parkinson's Disease. Int J Mol Sci 2022;23:1535. [PMID: 35163455 DOI: 10.3390/ijms23031535] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Salemi M, Lanza G, Mogavero MP, Cosentino FII, Borgione E, Iorio R, Ventola GM, Marchese G, Salluzzo MG, Ravo M, Ferri R. A Transcriptome Analysis of mRNAs and Long Non-Coding RNAs in Patients with Parkinson's Disease. Int J Mol Sci 2022;23:1535. [PMID: 35163455 DOI: 10.3390/ijms23031535] [Reference Citation Analysis]
11 Duarte P, Michalska P, Crisman E, Cuadrado A, León R. Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disease. Antioxidants 2022;11:247. [DOI: 10.3390/antiox11020247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Delpino FM, Figueiredo LM. Melatonin supplementation and anthropometric indicators of obesity: A systematic review and meta-analysis. Nutrition 2021;91-92:111399. [PMID: 34626955 DOI: 10.1016/j.nut.2021.111399] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
13 Li Y, Xu Z. Effects of Melatonin Supplementation on Insulin Levels and Insulin Resistance: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Horm Metab Res 2021;53:616-24. [PMID: 34496412 DOI: 10.1055/a-1544-8181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Suzuki K. Current Update on Clinically Relevant Sleep Issues in Parkinson's Disease: A Narrative Review. J Parkinsons Dis 2021;11:971-92. [PMID: 33896849 DOI: 10.3233/JPD-202425] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Pérez-Lloret S, Cardinali DP. Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson's Disease. Front Pharmacol 2021;12:650597. [PMID: 33935759 DOI: 10.3389/fphar.2021.650597] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
16 Chan V, Lo K. Efficacy of dietary supplements on improving sleep quality: a systematic review and meta-analysis. Postgrad Med J 2021:postgradmedj-2020-139319. [PMID: 33441476 DOI: 10.1136/postgradmedj-2020-139319] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Ferlazzo N, Andolina G, Cannata A, Costanzo MG, Rizzo V, Currò M, Ientile R, Caccamo D. Is Melatonin the Cornucopia of the 21st Century? Antioxidants (Basel) 2020;9:E1088. [PMID: 33167396 DOI: 10.3390/antiox9111088] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 20.0] [Reference Citation Analysis]
18 Morvaridzadeh M, Sadeghi E, Agah S, Nachvak SM, Fazelian S, Moradi F, Persad E, Heshmati J. Effect of melatonin supplementation on oxidative stress parameters: A systematic review and meta-analysis. Pharmacol Res 2020;161:105210. [PMID: 33007423 DOI: 10.1016/j.phrs.2020.105210] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]